Second-Generation Tyrosine Kinase Inhibitors (Pazopanib) in Renal Cell Carcinoma: Current Status

2014 ◽  
pp. 207-216
Author(s):  
Linda Cerbone ◽  
Cora N. Sternberg
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Renal Cell ◽  
Second Generation ◽  
Kinase Inhibitors ◽  
Current Status

scholarly journals Treatable causes of diarrhoea in patients on tyrosine kinase inhibitors for metastatic renal cell carcinoma

2019 ◽  
Vol 30 (1) ◽  
pp. 150-151
Author(s):  
S.V. Lightowlers ◽  
B. Greef ◽  
T. Eisen ◽  
A. Matakidou ◽  
K. Fife ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitors

Adjuvant tyrosine kinase inhibitors for renal cell carcinoma? No, thank you (at least for the present)

2018 ◽  
Vol 14 (22) ◽  
pp. 2223-2224 ◽  
Author(s):  
Alessandro Leonetti ◽  
Teresa Zielli ◽  
Sebastiano Buti
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Renal Cell ◽  
Kinase Inhibitors
Sign in / Sign up

Export Citation Format

Share Document